COVID-19: Should we continue using immunomodulatory drugs to treat our patients?
COVID-19: Should we continue using immunomodulatory drugs to treat our patients?
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer
COVID-19: A call for data on the impact on cancer patients
Cancer treatment in the age of COVID-19 and the current worldwide impact
Treating haematological cancers in Romania
The landscape of haematological cancers in India
Haematological malignancies: Latest advances from ASH 2019
Cancer care in Argentina
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019
Palliative care in India: The Bangalore Hospice Trust
How can we implement breast cancer screening India?
Transforming cancer care in India: The Tata Trusts cancer care program